UBS Maintains Neutral on Bruker, Raises Price Target to $65

Benzinga Newsdesk www.benzinga.com Positive 58.5%

Neg 0% Neu 0% Pos 58.5%

UBS analyst Dan Leonard maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target from $45 to $65.

Comments

No comments yet. Be the first!